FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers

Pilot Geared Toward Sponsors of Certain Oncology Drug Products Used with Certain In Vitro Diagnostic Tests to Identify Patients for Certain Cancer Treatments SILVER SPRING, Md., June 20, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration announced a new voluntary pilot…